In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: Relation to apoptosis and spontaneous regression

Journal of Pediatric Surgery

Volumn 31, Issue 2, 1996, Pages 251-257

  Oue, Takaharu ^a   Fukuzawa, Masahiro ^b   Kusafuka, Takeshi ^b   Kohmoto, Yosuke ^b   Imura, Kenji ^b   Nagahara, Susumu ^b   Okada, Akira ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

apoptosis; bcl 2; Neuroblastoma; nick end labeling

Indexed keywords

DNA FRAGMENT; PROTEIN BCL 2;

APOPTOSIS; CANCER REGRESSION; CANCER STAGING; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0030039499     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(96)90009-3     Document Type: Conference Paper

References (33)

1. Japanese Tumor Resistry on Pediatric Solid Tumors, Report of The Committee on Malignant Tumor. The Japanese Society of Pediatric Surgeons. J Jpn Soc Pediatr Surg 30:170-192, 1994
2. Evans A, Gerson J, Schnaufer L: Spontaneous regression of Neuroblastoma. Natl Cancer Inst Monogr 44:49-54, 1976
3. Carlsen NLT: Neuroblastoma: Epidemiology and pattern of regression. Am J Pediatr Hematol Oncol 14:103-110, 1992
4. Matsumura M, Tsunoda A, Nishi T, et al: Spontaneous regression of neuroblastoma detected by mass screening. Lancet 338:449-450, 1991
5. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: Basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972
6. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980
7. Clake PGH: Development cell death: Morphological diversity and multiple mechanisms. Anat Embryol 181:195-213, 1990
8. Cotter TG, Lennon SV, Glynn JG, et al: Cell death via apoptosis and its relationship to growth. Development and differentiation of both tumor and normal cells. Cancer Res 10:1153-1160, 1990
9. Williams: Programmed cell death: Apoptosis and oncogenesis: Cell 65:1097-1098, 1991
10. Raff M: Social controls on cell survival and cell death. Nature 356:397-400, 1992
11. Compton MM: A biochemical hallmark of apoptosis: Internucleosomal degeneration of the genome. Cancer Metastasis Rev 11:105-119, 1992
12. Vaux DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90:786-789, 1993
13. Linnik MD, Hatfield MD, Swope MD, et al: Induction of programmed cell death in a dorsal root ganglia x neuroblastoma cell line. J Neurol 24:433-446, 1993
14. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
15. Wijsman JH, Jonker RR, Keijzer R, et al: A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 41:7-12, 1993
16. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma. Cancer 27:371-378, 1971
17. Shimada H, Chatten J, Newton WA, et al: Histopathologic prognosis factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
18. Sawaguchi S, Takeda T, Iwafuchi M, et al: Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the study group of Japan. Cancer 66:1879-1887, 1990
19. Sawada T: Past and future of neuroblastoma screening in Japan. Am J Pediatr Hematol Oncol 14:320-326, 1992
20. Nakagawara A, Zaizen Y, Ikeda K, et al: Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later presenting neuroblastoma. Cancer 68:2037-2044, 1991
21. Hayashi Y, Hanada R, Yamamoto K: Biology of neuroblastoma in Japan found by mass screening. Am J Pediatr Hematol Oncol 14:342-347, 1992
22. Bessho F, Hashizume K, Nakajyo T, et al: Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 119:237-241, 1991
23. Piacentini M, Annicchiarico-Petruzzelli M, Oliverio S, et al: Phenotype-specific "tissue" transglutaninase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosis. Int J Cancer 52:271-278, 1992
24. Jensen LM, Zhang Y, Shooter EM: Steady-state polypeptide modulations associated with nerve growth factor (NGF)-induced terminal differentiation and NGF deprivation-induced apoptosis in human neuroblastoma cells. J Biol Chem 267:19325-19333, 1992
25. Kruman II, Kostenko MA, Gordon RY, et al: Differentiation and apoptosis of murine neuroblastoma cells NIE115. Biochem Biophys Res Commun 191:1309-1318, 1993
26. Tsujimoto Y, Croce C: Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5211-5218, 1986
27. Vaux DL, Cory S, Adams J: bcl-2 gene promotes hematopoietic cell survival and cooperates with c-myc to immortalize pre-B-cells. Nature 335:440-442, 1988
28. Hockenbery D, Nunez G, Milliman C, et al: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
29. Reed JC, Meister L, Tanaka S, et al: Differential expression of the bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 51:6529-6538, 1991
30. Castle VP, Heidelberger KP, Bromber J, et al: Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 143:1543-1550, 1993
31. Falcione M, Milligan BCD, Schwartz C, et al: Prevention of neocarzinostain-induced cell death and morphologic change in SK-N-SH human neuroblastoma cells by continuous exposure to nerve growth factor. Biochem Pharmacol 46:731-738, 1993
32. Nakagawara A, Arima M, Christopher G, et al: Inverse relationship between trk expression and N-myc amplification in human neuroblastoma. Cancer Res 52:1364-1368, 1992
33. Garcia I, Marinou I, Tsujimoto Y, et al: Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258:302-304, 1992